Event
Title: |
FountainBlue's Life Science Entrepreneurs' Forum |
|
| Date: | Monday, August 18, 2008 |
|
| Time: | 5:30 - 7:30 PM |
|
| Location: | DLA Piper LLP
|
|
| Sponsor: | Astia |
|
| Event details: | Overview:
As Big Pharma and emerging life science companies adopt a range of different strategies for their collaboration activities, collaboration transactions are becoming increasingly varied and complex. While creating value for both sides, collaborations present unique challenges which should be addressed at the outset to ensure the success of the collaboration. This month's panel will discuss key issues in structuring and executing life science collaborations and examine their impact on the collaboration partners and other stakeholders, including investors.
Facilitator/moderator: J. Howard Clowes, Partner, DLA Piper LLP Panelists:
· Adam Bristol, Investor, Biotechnology Value Fund (tentative) · Jim I McLoughlin, Executive Director, Worldwide Business Development & Pfizer Venture Capital; Pfizer Inc. - Biotherapeutics and Bioinnovations Center · John Wulf, EVP & CBO, Trellis Bioscience (tentative) · Other Panelists to be confirmed
|
|
| Information and Registration: | Additional information about our life science entrepreneurs' forum and notes from our previous meetings are available at http://www.SVLifeScience.com Join the Life Science community by visiting http://finance.groups.yahoo.com/group/SVLifeScience or our Life Science MeetUp at http://entrepreneur.meetup.com/1638/. Pre-register for $18-$30, by visiting http://www.acteva.com/booking.cfm?bevaid=146096 by noon on Friday, August 15. On-site registration is $40 plus $4 in fees. NO SERVICE PROVIDERS PLEASE. |
|
